arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Akebia Therapeutics, Inc.

AKBA Health Care Biotechnology: Pharmaceutical Preparations
$0.57
▼ -3.1% Today
as of Oct 23, 16:45 ET
Last 30 days -41.12% Sep 14 → Oct 23
$0.53 $0.65 $0.77 $0.89 $1.01 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$0.57
High
$0.60
Low
$0.56
Volume
$11M
Avg Vol
$5M
Mkt Cap
$241M
P/E (TTM)
—
Beta
—
52w High
$3.20
52w Low
$0.54
Div Yield
—
Shares Out
$272M

Recent Press Releases & News last 60 days · 7 items

▸ Show all 7 press releases & news Free account →

AKBA earnings at a glance

The options market is pricing a move of about ±16.3% after the report, a range of roughly $0.48 to $0.66 from today's $0.57. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±13.4% on average; after the most recent report on May 7, 2026 it moved -20.3%. That means options currently expect more movement than AKBA has typically delivered. AKBA beat the consensus EPS estimate in 2 of its last 3 reported quarters. Implied volatility is currently 83%. The share price of $0.57 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.54
$3.20
1% of range
Avg surprise (last 3)
+33.3%
Avg reaction (last 2)
-6.9%
50% positive
Latest IV / EM
83%
EM ±16.3% · $1 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.15$-0.10$-0.06$-0.01$0.03 Actual $-0.15Actual $-0.06Actual $-0.08Actual $-0.09Actual $-0.04Actual $-0.10Actual $0.03Est $-0.03Est $-0.02Actual $-0.03Est $-0.01Actual $-0.03 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-20M$1M$23M$44M$66M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.03 — — — — financials
Thu May 7, 2026Mar/2026 $-0.03 $-0.01 -200.0% -200.0% -20.3% earnings
Mon Nov 10, 2025Sep/2025 — — — — — earnings
Thu Aug 7, 2025Jun/2025 — $-0.02 +100.0% — — earnings
Thu May 8, 2025Mar/2025 $0.03 $-0.03 +200.0% — +6.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.10 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.04 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.09 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.08 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.06 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.15 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$49M$54M—$59M$62M$57M—$37M
Cost of revenue$10M$12M—$9M$10M$8M—$14M
Gross profit————————
Operating income$-6M$-5M—$4M$14M$14M—$-13M
Net income$-9M$-9M—$540,000$247,000$6M—$-20M
EPS (diluted)$-0.03$-0.03———$0.03—$-0.10

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$156M$163M$185M$166M$137M$113M$52M$34M
Inventory$13M$13M$16M$19M$17M$20M$16M$20M
Total current assets$230M$243M$253M$258M$235M$204M$114M$100M
Total assets$350M$363M$377M$364M$346M$310M$221M$207M
Long-term debt$25M$36M$48M$48M$47M$47M$39M$38M
Total liabilities$325M$335M$344M$323M$316M$286M$270M$258M
Total equity$25M$27M$33M$42M$29M$25M$-49M$-50M

Implied volatility — last 90 days

65%327%589%851%1113% Jun 19 — IV 106% · EM ±23.4%Jun 22 — IV 132% · EM ±27.5%Jun 23 — IV 136% · EM ±27.8%Jun 30 — IV 153% · EM ±26.3%Jul 01 — IV 175% · EM ±29.2%Jul 02 — IV 199% · EM ±32.3%Jul 03 — IV 206% · EM ±32.3%Jul 07 — IV 84% · EM ±11.0%Jul 08 — IV 84% · EM ±10.5%Jul 09 — IV 89% · EM ±10.5%Jul 20 — IV 132% · EM ±31.2%Jul 21 — IV 181% · EM ±42.1%Jul 22 — IV 200% · EM ±45.6%Jul 27 — IV 178% · EM ±37.1%Jul 29 — IV 79% · EM ±15.8%Jul 30 — IV 172% · EM ±33.6%Aug 03 — IV 86% · EM ±15.3%Aug 04 — IV 66% · EM ±11.4%Aug 11 — IV 218% · EM ±28.9%Aug 12 — IV 402% · EM ±50.4%Aug 13 — IV 195% · EM ±23.0%Aug 14 — IV 259% · EM ±28.6%Aug 17 — IV 1114% · EM ±93.0%Aug 18 — IV 487% · EM ±35.2%Sep 02 — IV 92% · EM ±15.3%Sep 03 — IV 93% · EM ±15.0%Sep 21 — IV 77% · EM ±16.0%Sep 24 — IV 83% · EM ±16.3%

Sector peers

AKBA earnings FAQ

What is AKBA's expected move for earnings?

Options currently price a move of about ±16.3%, or $0.09 per share either way from $0.57.

How does AKBA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±13.4%, up 1 times and down 1 times.

What is AKBA's implied volatility?

AKBA's at-the-money implied volatility is about 83% based on the latest options snapshot.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.